Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free SBMFF Stock Alerts

Sino Biopharmaceutical (SBMFF) Short Interest Ratio & Short Volume

Sino Biopharmaceutical logo
$0.61 0.00 (0.00%)
As of 08/14/2026
Compare

Sino Biopharmaceutical Short Interest Overview

As of July 31, 2026, Sino Biopharmaceutical (SBMFF) had a short interest of 27.55 million shares sold short, representing 0.15% of the public float. This marks a -49.19% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.0, meaning it would take 0.0 days of the average trading volume of 201 shares to cover all short positions.

Current Short Interest
27,548,732 shares
Previous Short Interest
54,218,169 shares
Change Vs. Previous Month
-49.19%
Dollar Volume Sold Short
$17.55 million
Short Interest Ratio
0.0 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
18,760,720,000 shares
Short Percent of Float
0.15%
Today's Trading Volume
0 shares
Average Trading Volume
201 shares
Today's Volume Vs. Average
0%
Short Selling Sino Biopharmaceutical?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Sino Biopharmaceutical and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

SBMFF Short Interest Over Time

SBMFF Days to Cover Over Time

SBMFF Percentage of Float Shorted Over Time

Sino Biopharmaceutical Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202627,548,732 shares $17.55 million -49.2%0.1%0 $0.64
7/15/202654,218,169 shares $34.54 million -25.9%0.3%999.99 $0.64
6/30/202673,193,307 shares $44.04 million 0.0%0.4%999.99 $0.60
6/15/202673,209,767 shares $46.35 million +10.9%0.4%0 $0.63
5/29/202665,990,767 shares $41.78 million -2.1%0.4%999.99 $0.63
5/15/202667,396,860 shares $46.66 million -26.6%0.4%999.99 $0.69
4/30/202691,783,266 shares $69.78 million -9.4%0.5%0 $0.76
4/15/2026101,270,266 shares $76.99 million +9.1%0.5%999.99 $0.76
3/31/202692,848,845 shares $70.43 million -5.3%0.5%999.99 $0.76
3/13/202698,069,575 shares $81.39 million +35.7%0.5%999.99 $0.83
2/27/202672,283,620 shares $60.71 million +0.1%0.4%0 $0.84
2/13/202672,184,620 shares $60.63 million +3.0%0.4%999.99 $0.84
1/30/202670,055,620 shares $61.85 million -11.3%0.4%999.99 $0.88
1/15/202678,955,359 shares $70.35 million -25.1%0.4%999.99 $0.89
12/31/2025105,368,569 shares $91.89 million +1.8%0.6%999.99 $0.87
12/15/2025103,492,892 shares $90.26 million +1.3%0.6%0 $0.87
11/28/2025102,123,573 shares $89.06 million -12.1%0.5%999.99 $0.87
11/14/2025116,202,796 shares $100.56 million +12.4%0.6%999.99 $0.87
10/31/2025103,433,396 shares $89.19 million +114.8%0.6%41224.95 $0.86
10/15/202548,159,600 shares $43.82 million +12.4%0.3%32106.4 $0.91
9/30/202542,843,000 shares $46.70 million +25.2%N/A85686.1 $1.09
9/15/202534,229,400 shares $39.48 million -30.6%N/A38032.7 $1.15
8/31/202549,345,500 shares $48.81 million +306.0%0.3%0 $0.99
8/15/202512,155,500 shares $12.02 million -14.6%N/A11050.5 $0.99
7/31/202514,227,500 shares $13.55 million -29.4%0.1%2496.1 $0.95
7/15/202520,145,300 shares $14.34 million -27.6%N/A3730.6 $0.71
6/30/202527,835,800 shares $19.28 million +75.6%0.1%8187 $0.69
6/15/202515,848,500 shares $11.17 million -40.6%0.1%3521.9 $0.70
5/31/202526,678,100 shares $14.97 million -28.3%0.1%38111.6 $0.56
5/15/202537,216,500 shares $18.42 million +8.6%0.2%124055 $0.50
4/30/202534,274,000 shares $16.91 million -0.4%N/A342740 $0.49
4/15/202534,425,500 shares $16.10 million +125.0%0.2%43031.9 $0.47
3/31/202515,300,300 shares $6.95 million -79.5%0.1%10200.2 $0.45
3/15/202574,612,700 shares $31.64 million -2.9%0.4%0 $0.42
2/28/202576,813,200 shares $32.57 million -2.3%0.4%256044 $0.42
2/15/202578,597,300 shares $29.09 million -7.2%0.4%5239.8 $0.37
1/31/202584,686,700 shares $31.49 million +185.5%N/A846867 $0.37
1/15/202529,665,400 shares $12.20 million +209.7%N/A0 $0.41
12/31/20249,577,400 shares $3.94 million +10.3%N/A13682 $0.41
12/15/20248,683,300 shares $3.68 million +20.6%N/A6202.4 $0.42
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
11/30/20247,201,300 shares $3.01 million -10.5%N/A3273.3 $0.42
11/15/20248,048,300 shares $3.46 million +26.8%N/A1490.4 $0.43
10/31/20246,347,300 shares $3.00 million +427.5%N/A6347.3 $0.47
10/15/20241,203,300 shares $565.55 thousand +755.8%N/A0 $0.47
9/30/2024140,600 shares $66.08 thousand +418.8%N/A82.7 $0.47
9/15/202427,100 shares $10.34 thousand +234.6%N/A54.2 $0.38
8/31/20248,100 shares $3.09 thousand -99.5%N/A13.5 $0.38
8/15/20241,674,100 shares $568.52 thousand -91.5%N/A1116.1 $0.34
7/31/202419,631,100 shares $7.07 million -40.3%N/A32718.5 $0.36
7/15/202432,903,100 shares $12.17 million 0.0%N/A36559 $0.37
6/30/202432,908,100 shares $10.24 million +236,648.9%N/A41135.1 $0.31
6/15/202413,900 shares $4.92 thousand -100.0%N/A12.6 $0.35
5/31/202441,764,200 shares $13.15 million -31.3%N/A208821 $0.31
5/15/202460,748,200 shares $19.13 million +62.4%N/A0 $0.31
4/30/202437,411,200 shares $11.78 million +142.6%N/A124704 $0.31
4/15/202415,423,100 shares $5.90 million +190.5%N/A19278.9 $0.38
3/31/20245,308,700 shares $1.84 million +0.0%N/A10617.4 $0.35
3/15/20245,306,700 shares $1.92 million -5.1%N/A0 $0.36
2/29/20245,588,700 shares $2.03 million -48.3%N/A553.3 $0.36
2/15/202410,809,700 shares $3.70 million -68.8%N/A108097 $0.34
1/15/20245,514,700 shares $2.29 million -0.3%N/A0 $0.42
12/31/20235,533,000 shares $2.30 million +43.1%N/A32168.5 $0.42
12/15/20233,867,600 shares $1.49 million +1.7%N/A19338 $0.38
11/30/20233,804,400 shares $1.88 million +2.3%N/A0 $0.49
11/15/20233,718,500 shares $1.84 million -79.2%N/A1430.2 $0.49
10/31/202317,838,400 shares $5.89 million +3.8%N/A44596 $0.33
10/15/202317,182,200 shares $5.90 million +13.9%N/A21477.8 $0.34
9/30/202315,090,700 shares $5.13 million +58.6%N/A5389.5 $0.34
9/15/20239,517,500 shares $3.52 million +3.7%N/A0 $0.37
8/31/20239,174,500 shares $3.39 million +131.9%N/A4432.1 $0.37
8/15/20233,955,800 shares $1.56 million -38.0%N/A1798.1 $0.40
7/31/20236,383,200 shares $2.87 million -37.6%N/A1877.4 $0.45
7/15/202310,224,700 shares $4.40 million -13.2%N/A1704.1 $0.43
6/30/202311,784,600 shares $4.61 million +44.3%N/A19641 $0.39
6/15/20238,168,200 shares $3.84 million +52.9%N/A4804.8 $0.47
5/31/20235,342,200 shares $2.62 million -3.8%N/A574.4 $0.49
5/15/20235,554,200 shares $2.89 million -3.8%N/A5554.2 $0.52
4/30/20235,774,400 shares $3.14 million +29.4%N/A57744 $0.54
4/15/20234,461,200 shares $2.50 million -51.8%N/A874.7 $0.56
3/31/20239,264,000 shares $4.82 million -12.6%N/A0 $0.52
3/15/202310,603,300 shares $5.51 million +9.8%N/A4418 $0.52
2/28/20239,657,100 shares $5.36 million +228.5%N/A4023.8 $0.56
2/15/20232,939,600 shares $1.64 million +101.6%N/A3674.5 $0.56
1/31/20231,458,000 shares $815.31 thousand +14.5%N/A633.9 $0.56
1/15/20231,273,100 shares $802.05 thousand -57.0%N/A40.5 $0.63
12/30/20222,957,800 shares $1.73 million -9.6%N/A394.4 $0.59
12/15/20223,271,300 shares $1.84 million -19.8%N/A1022.3 $0.56
11/30/20224,076,700 shares $2.27 million -2.7%N/A3397.3 $0.56
11/15/20224,187,900 shares $2.35 million +9.2%N/A1102.1 $0.56
10/31/20223,836,100 shares $1.90 million +49.9%N/A892.1 $0.50
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (Ad)

In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon adviser Jim Rickards publicly predicted a Trump victory before election night. Now Rickards is issuing a new forecast he calls a potential mid-term meltdown, one he believes could send shockwaves through financial markets.tc pixel

See Jim Rickards' full market warning and what it means for your portfolio
10/15/20222,558,900 shares $1.20 million -11.4%N/A1705.9 $0.47
9/30/20222,888,900 shares $1.27 million -34.5%N/A1203.7 $0.44
9/15/20224,411,900 shares $2.10 million -30.3%N/A1470.6 $0.48
8/31/20226,326,700 shares $3.61 million +2.8%N/A266.9 $0.57
8/15/20226,153,100 shares $3.32 million -2.2%N/A30765.5 $0.54
7/31/20226,292,900 shares $3.52 million +199.5%N/A8989.9 $0.56
7/15/20222,100,900 shares $1.22 million -7.4%N/A21009 $0.58
6/30/20222,268,900 shares $1.32 million +7.1%N/A306.6 $0.58
6/15/20222,117,800 shares $1.09 million +1.4%N/A4235.6 $0.51
5/31/20222,087,800 shares $1.13 million -38.2%N/A366.3 $0.54
5/15/20223,377,000 shares $1.55 million -37.3%N/A3070 $0.46
4/30/20225,384,000 shares $2.70 million -0.7%N/A1994.1 $0.50
4/15/20225,419,900 shares $2.91 million -23.4%N/A256.9 $0.54
3/31/20227,072,900 shares $4.41 million -31.7%N/A1813.6 $0.62
3/15/202210,356,200 shares $5.03 million -16.5%N/A7966.3 $0.49
2/28/202212,402,200 shares $8.09 million +12.9%N/A31005.5 $0.65
2/15/202210,986,200 shares $7.64 million -21.8%N/A15694.6 $0.70
1/31/202214,056,200 shares $9.36 million +4.9%N/A846.8 $0.67
1/15/202213,398,400 shares $9.95 million -47.0%N/A2679.7 $0.74
12/31/202125,300,800 shares $16.81 million +4.8%N/A4438.7 $0.66
12/15/202124,145,300 shares $16.82 million +6.0%N/A8942.7 $0.70
11/30/202122,787,100 shares $15.98 million +7.1%N/A32553 $0.70
11/15/202121,276,000 shares $14.95 million -6.3%N/A106380 $0.70
10/29/202122,709,600 shares $17.10 million +9.1%N/A37849.3 $0.75
10/15/202120,810,700 shares $15.07 million +1.4%N/A17342.3 $0.72
9/30/202120,522,000 shares $17.05 million -1.6%N/A205220 $0.83
9/15/202120,857,800 shares $17.33 million -12.4%N/A10428.9 $0.83
8/31/202123,800,300 shares $19.04 million -15.1%N/A5666.7 $0.80

SBMFF Short Interest - Frequently Asked Questions

Short interest is the volume of Sino Biopharmaceutical shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 27,548,732 shares of SBMFF short. 0.15% of Sino Biopharmaceutical's shares are currently sold short. Learn More on Sino Biopharmaceutical's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.15% of Sino Biopharmaceutical's floating shares are currently sold short.

Sino Biopharmaceutical saw a decrease in short interest in July. As of July 31st, there was short interest totaling 27,548,732 shares, a decrease of 49.2% from the previous total of 54,218,169 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.15% of Sino Biopharmaceutical's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Sino Biopharmaceutical: CSL Limited Sponsored ADR (0.02%), Revolution Medicines, Inc. (5.82%), Biogen Inc. (3.70%), Insmed, Inc. (5.31%), Alnylam Pharmaceuticals, Inc. (3.62%), Roivant Sciences Ltd. (5.37%), Incyte Corporation (6.03%), WuXi Biologics (Cayman) Inc. (0.00%), Moderna, Inc. (13.98%), BioNTech SE Sponsored ADR (1.21%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling SBMFF is an investing strategy that aims to generate trading profit from Sino Biopharmaceutical as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Sino Biopharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SBMFF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SBMFF, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like SBMFF:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for OTCMKTS:SBMFF is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Buy These Stocks Before August 31st
Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...
TradeSmith | Sponsoredtc pixel
This tiny launch company operates next to SpaceX and Blue Origin
A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken...
Freedom Financial | Sponsoredtc pixel
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel